Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression.
AUTOR(ES)
Perkins, N D
RESUMO
Human immunodeficiency virus type 1 (HIV-1) gene expression is regulated by an enhancer region composed of multiple potential cis-acting regulatory sites. Here, we describe binding sites for the transcription factor AP-2 in the HIV-1 long terminal repeat which modulate HIV enhancer function. One site is embedded within the two previously described kappa B elements, and a second site is detected further downstream. DNase I footprinting and electrophoretic mobility shift assay experiments demonstrated that AP-2 binds to the site between the kappa B elements. Interestingly, AP-2 and NF-kappa B bind to this region in a mutually exclusive manner. Mutations which disrupt this AP-2-binding site lower basal levels of transcription but do not affect NF-kappa B-mediated induction by tumor necrosis factor alpha in Jurkat T leukemia cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=237111Documentos Relacionados
- Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.
- Transcription factor AP-2 activates gene expression of HTLV-I.
- The genomic structure of the human AP-2 transcription factor.
- Transcription factor AP2 and its role in epidermal-specific gene expression.
- Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene